Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.890 +0.250 (+9.47%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Iovance (IOVA) Q2 Revenue Jumps 93% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

August 07, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Is Iovance Biotherapeutics Stock Due for a Big Rally? ↗

July 30, 2025

The biotech stock has been picking up steam of late -- but will it last?

Via The Motley Fool

This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy? ↗

July 29, 2025

Even the average price estimate for this stock suggests it can soar, but not everyone's convinced.

Via The Motley Fool

Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025

July 24, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 24, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

July 23, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

These stocks are gapping in today's session ↗

July 23, 2025

The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Analyst Expectations For Iovance Biotherapeutics's Future ↗

July 23, 2025

Via Benzinga

Health In Tech (NASDAQ: HIT) Posts Blowout Q2, Stock Responds – HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside

July 22, 2025

Via AB Newswire

Topics Artificial Intelligence

Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock ↗

July 22, 2025

The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment.

Via Investor's Business Daily

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday ↗

July 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside ↗

July 21, 2025

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

IOVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

July 15, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

July 14, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

FINAL IOVANCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Iovance Biotheapeutics, Inc. (IOVA) to Inquire About Their Rights in Class Action Lawsuit

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) - July 14, 2025 Deadline to Join - Contact Levi & Korsinsky

July 14, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) - July 14, 2025 Deadline to Join - Contact Levi & Korsinsky

July 14, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

July 14, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

IOVANCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iovance Biotherapeutics, Inc. and Urgently Encourages Investors to Contact the Firm

July 12, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

IOVA Deadline: Rosen Law Firm Urges Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

July 11, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

July 11, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.